Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem
PubMed
18559909
DOI
10.1210/jc.2008-0746
PII: jc.2008-0746
Knihovny.cz E-zdroje
- MeSH
- adiponektin krev MeSH
- biologická adaptace fyziologie MeSH
- dospělí MeSH
- fibroblastové růstové faktory krev fyziologie MeSH
- index tělesné hmotnosti MeSH
- inzulin krev MeSH
- leptin krev MeSH
- lidé MeSH
- mentální anorexie krev etiologie MeSH
- přijímání potravy fyziologie MeSH
- průřezové studie MeSH
- studie případů a kontrol MeSH
- tělesná hmotnost fyziologie MeSH
- trijodthyronin krev MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- adiponektin MeSH
- ADIPOQ protein, human MeSH Prohlížeč
- FGF19 protein, human MeSH Prohlížeč
- fibroblast growth factor 21 MeSH Prohlížeč
- fibroblastové růstové faktory MeSH
- inzulin MeSH
- leptin MeSH
- trijodthyronin MeSH
CONTEXT: Fibroblast growth factor 19 (FGF19) and FGF21 are novel metabolic regulators that improve insulin sensitivity and decrease adiposity in mice. However, little is known about the nutritional regulation of these factors in humans. OBJECTIVE: The objective of this study was to measure plasma FGF19 and FGF21 levels in patients with anorexia nervosa (AN) and to explore its relationship with anthropometric and endocrine parameters. DESIGN: This was a single-center cross-sectional study. SETTING: The study was performed in a university hospital. PATIENTS: Seventeen untreated women with a restrictive type of AN and 17 healthy women (control group) were included. MAIN OUTCOME MEASURES: Fasting plasma FGF19 and FGF21, serum insulin, leptin, soluble leptin receptor, adiponectin, resistin, and C-reactive protein were the main outcome measures. RESULTS: Plasma FGF19 levels did not significantly differ between the groups studied, whereas plasma FGF21 levels were significantly reduced in AN relative to the control group. Plasma FGF21 positively correlated with body mass index and serum leptin and insulin and was inversely related to serum adiponectin in both groups. In contrast, plasma FGF19 was not related to any of parameters studied. Partial realimentation significantly reduced plasma FGF21 levels in AN. CONCLUSION: Circulating levels of FGF21 but not FGF19 are strongly related to body weight and serum levels of leptin, adiponectin, and insulin in both anorectic and normal-weight women. We suggest that reduced plasma FGF21 levels could be involved in the pathophysiology of AN or in a complex adaptive response to this disease.
Citace poskytuje Crossref.org